Ipamorelin functions through activation of the growth hormone secretagogue receptor (GHS-R1a), commonly known as the ghrelin receptor
4 weeks Minimum interval between dose increases 2mg to 12mg Phase 2 dose range (Jastreboff 2023) ~12 weeks Time to reach 12mg on standard protocol 24.2% Weight loss at 12mg, 48 weeks (Phase 2) Investigational Drug Warning Retatrutide (LY3437943) is not FDA-approved as of April 2026
2016) and bodybuilding and athletic performance enhancement (Karlic and Lohninger 2004)
CJC-1295 + Ipamorelin: Stimulate growth hormone pulsatility Improve body composition, sleep, and cellular repair BPC-157: Supports tendon, ligament, muscle, and gut repair Reduces inflammation TB-500: Enhances tissue regeneration Complements BPC-157 MOTS-C: Mitochondrial peptide activating AMPK Improves metabolism, insulin sensitivity, and exercise tolerance THE SCIENCE BEHIND PEPTIDE ACTION MC4R activation libido and arousal (PT-141) cAMP IGF-1 and growth hormone signaling (CJC/Ipamorelin) WNT activation tissue healing (BPC-157) ECM remodeling collagen formation (GHK-Cu) AMPK activation metabolic efficiency (MOTS-C) PEPTIDES AND SEXUAL HEALTH For Men: Erectile dysfunction Low libido Performance anxiety Poor recovery Post-prostate treatment dysfunction For Women: Perimenopause and menopause symptoms Low arousal Stress-related desire changes Sexual pain Fatigue and mood changes SAFETY AND MEDICAL OVERSIGHT All peptide therapy at our center includes: Comprehensive medical evaluation Baseline labs Ongoing monitoring Clear dosing guidance WHY PATIENTS CHOOSE THE CENTER FOR ADVANCED UROLOGY We integrate urology, hormone therapy, and longevity medicine into a single, comprehensive care model
Some help with weight loss, while others are better for managing diabetes and reducing the risk of heart disease
Open communication with healthcare providers remains essential for optimal outcomes
